If coronavirus vaccines are restricted to seniors and those at high risk, parents of young children and relatives of ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday announced that COVID-19 vaccines are no longer recommended for healthy ...

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.